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Book Reviews
Advances in Enzyme-Regulation. Vol. 31
Edited by G. Weber, Oxford: Pergamon Press, 1991, 496 pp.
£200.00.
The title of this multiauthor volume is a little misleading.
The contributions are based on the proceedings of the 31st
annual symposium on the Regulation of Enzyme Activity
and Synthesis in Normal and Neoplastic Cells. This was held
in Indianopolis in October 1990 so the material is fairly
topical. There are 24 papers covering a wide range of sub-
jects. Not all of these have much connection with enzyme
regulation, but a number will be of interest to cancer re-
searchers. In particular there is quite a lot here for those
interested in anticancer drug development. Space precludes
mentioning all of the contributions, but some of these are
discussed to give a flavour of the volume.
The chapter by Jackman et al. shows how an integration
of enzymology with other investigations had led to the
clinical evaluation of improved folate-based thymidylate
synthetase inhibitors. Harrap and colleagues describe their
progress in developing orally active platinum coordination
complexes which also circumvent some forms of cisplatin
resistance. The rationale for the combined inhibition of de
novo and salvage pathways for purine and pyrimidine meta-
bolism is reviewed by Weber et al.
I personally enjoyed the updates on the multiple forms of
protein kinase C including their possible roles in cancer cell
signalling (Ohno et al.) and on the regulation of the gluta-
thione transferase P gene (Muramatsu et al.) and the
CYPIAJ gene which encodes the cytochrome P450 lAl (Lus-
ska et al.).
The review by Estabrook et al. gives some nice samples of
the value of expressing cloned P450 genes in bacterial, yeast
or mammalian host cells. Schwab provides a critical piece on
N-myc and Capitani and colleagues discuss their data on
nuclear inositol lipids in the context of the growing realisa-
tion that the isoitol lipid - protein kinase C signalling path-
ways may exist within the nucleus itself. A major problem
with both antibodies and antisense oligonucleotides as thera-
peutic agents concerns the delivery of these large molecules
and Severin et al. show how 'hydrophobisation' with fatty
acid residues may improve their antiviral activity.
Inevitably in this type of production there are stylistic
disparities between contributions, some being pure reviews,
but most being more formal presentations of in-house data.
Also inevitably, most of the material has appeared or will
appear elsewhere in the literature. I found some of 'Session'
titles rather puzzling. The book is also expensive. However,
the articles are readable and interesting and the quality ofthe
editing and production is excellent. There should be some-
thing in this pot pourri to interest most cancer researchers
(certainly most cancer pharmacologists). I for one found it
worth perusing, not least for the charming and informative
personal anecdote from Nobel Laureate George Hitchings
which concludes the book.
P. Workman
Immunodiagnosis of Cancer (second edition)
Edited by R.B. Herberman & D.W. Mercer, New York:
Marcel Dekker Inc., 1990, 712 pp. $150 (USA & Canada),
$180.00 (Others).
This is the second edition of Immunodiagnosis ofCancer, the
53rd publication in an immunology series going back more
than a decade. Since the previous edition was published in
1979, there has been a vast expansion in immunological
techniques including the widespread availability and use of
monoclonal antibodies. In addition, the increasing sensitivity
and specificity of assay procedures has lead to much greater
complexity in this field. In this edition, the editors aim to
acquaint the reader with both the theoretical and practical
aspects ofimmunodiagnosis and its relevance in cancer. They
cover experimental design, methodology, organ site-assoc-
iated tumour markers and non organ site-restricted tumour
markers.
The standard of contributions in this book is generally
high. There is a concise overview of the value of serum
markers in a number of common tumour types emphasising
the uses (and limitations) of a panel approach. The meth-
odology section reviews the majority of useful techniques in
detail; as well as monoclonal antibodies (production and
usage) and a full discussion of immunoassay technology,
molecular biological techniques and flow cytometry are also
covered. The organ site-associated tumour markers are re-
viewed in seventeen chapters, each devoted to a particular
tumour site or type; much of this gives us interesting insight
into the biology of these tumours. The immunophenotypic
classification of lymphoma and leukaemia using a few crucial
commercially available immunocytochemical markers, and
the use of serum markers to assess response of certain
tumours to treatment, are of particular practical value. The
fourth section deals with topics such as immunoglobulins,
acute phase proteins, immune complexes, fibronectin, serum
isoenzymes, mucin glycoproteins and placental proteins. Each
of these chapters gives an up to date statement of present
knowledge with an extensive literature review.
The text is liberally sprinkled with high quality line draw-
ings and tables where appropriate. The book highlights those
areas in which there is uncertainty and suggests a wide area
of potential expansion in the future. It must be regarded as a
key reference text for both research workers and clinicians
with an interest in tumour pathology and immunology.
J.B. Schofield
N.A. Wright
Non-Melanocytic Tumors of the Skin
Atlas of Tumor Pathology, Third Series, No. 1.
G.F. Murphy & D.E. Elder, Washington: AFIP, 1991,
287pp. $45.00.
Melanocytic Tumors of the Skin
Atlas of Tumor Pathology, Third Series, No. 2.
D.E. Elder & G.F. Murphy, Washington: AFIP, 1991,
216pp. $45.00
Surgical pathologists sometimes feel regarded by their clinical
colleagues as a modern manifestation of the oracle of ancient
times. Instead of sacrificing an animal and then examining its
entrails to foretell the future we now remove part of the
patient instead and then expect the pathologist to provide
detailed prognostic information on the biopsy material that is
submitted to the laboratory. Of course the ancient Greeks
did not go to any old oracle, but would travel to Delphi for
the best available opinion. In present times it is not always
appreciated that the choice of surgical pathologist may be as
important as the choice of oracle in those days, and can
easily be as important as the choice of surgeon or oncologist
in determining the changes of success in the diagnosis and
management of patients with tumours. The experience of the
British Melanoma Club over the last decade has shown
clearly that in the field of pigmented lesions there is con-
siderable interobserver variation, with universal agreement on
diagnosis hard to find amongst a group of motivated and1206 BOOK REVIEWS
interested pathologists: a failing possibly mitigated by the
lack of a reliable baseline in existing books.
So what can surgical pathologists do to emulate their
ancient forebears? Most rely on experience, supported by a
selection of books to jog the memory, widen the palette of
pathological possibilities and, as a last resort, aid in the
process of wallpaper matching, for a diagnosis can only be
made if you are aware of the possibility of its existence. The
multi-volume Atlas of Tumor Pathology, produced by the
Armed Forces Institute of Pathology in Washington and
universally known to pathologists as the 'Fascicles', stand as
a benchmark in surgical pathology.
Produced in house to a high print quality and virtually
cost price they are usually the best place to look for that rare
condition that evades the seeking eye in many other books
on the shelf. I have never seen the Fascicle from the first
series, produced over 30 years ago in loose leaf form, by Dr
Herbert Z. Lund. The second series were produced as bound
monographs. Most departments must have a set, but sadly
there was no Fascile on skin tumours. The third series will
appear with Juan Rosai as the Editor. If he maintains the
standards of the previous series and of his own book of
surgical pathology, widely regarded as the best available,
then we can expect even greater things.
The first two Fascicles of the third series have appeared
together: the first, on 'Non-Melanocytic Tumors of the Skin'
by Murphy and Elder and the second on 'Melanocytic
Tumors of the Skin' by Elder and Murphy.
Fascicle 1 provides a survey of epidermal, adnexal, lym-
phoid and dermal stromal tumours. Some aspects of soft
tissue tumours are excluded, because they will be covered in
a subsequent Fascicle. The descriptions and classifications
that are used are clearly stated, and follow a logical path.
The illustrations are uniformly good. Most are half tones,
but there are also several pages of colour photographs used
to illustrate the clinical appearance of some of the tumours.
The text gives for each entitity a definition, a description of
clinical and histologic features and where relevant a discus-
sion of the differential diagnosis.
Fascicle 2 is even more interesting because it is the first
real opportunity that we have had to read a sustained state-
ment from the group in Philadelphia that has provided such
a lead in the pathology of melanoma and dysplastic naevi.
After descriptions of the various kinds of benign nevi there is
a clear description of dysplastic nevi. The discussion of
melanoma included descriptions of the concepts of radial and
vertical growth phases and of the prognostic models that
they have developed. The Fascicle concludes with sections
describing unusual forms of melanoma, metastases and non-
neoplastic hyperpigmentations. Once again the figures are of
high quality and colour is used to show clinical appearances
of representative lesions.
These two Fascicles have succeeded in their aim of describ-
ing cutaneous tumours and in providing a baseline for their
diagnosis. Few if any entities are missing. The pathologist
who has copies by the microscope will have scant excuse for
ignorance or misinterpretation of the many varieties of skin
tumours described here and with their aid will be able to
adopt an aura of omnipotence in dermatological diagnosis.
At the price they are a bargain and must be an essential
purchase for every histopathology or dermatopathology
department.
N. Kirkham
Practical Radiotherapy Planning. Second Edition
J. Dobbs, A. Barrett and D. Ash, London: Edward Arnold,
1991, 303 pp. £40.00.
The first edition of Practical Radiotherapy Planning filled an
important gap and has become a standard text for all
radiotherapists in training. There can be few radiotherapy
department libraries without a copy.
The second edition has been significantly updated and
expanded. It contains two new chapters, one on the prin-
ciples of brachytherapy and another dealing with bone and
soft tissues sarcomas. In addition sections on brachytherapy
have been added to those chapters where this technique can
make an important contribution to treatment. The recom-
mendations of the ICRU for definitions of volumes and dose
specifications have been adopted and modifications made to
the text and illustrations accordingly.
The book is concise, well laid out and clearly illustrated. It
is highly recommended to all doctors, physicists and radio-
graphers involved in treatment planning.
M.Leslie
Film-Screen Mammography. An Atlas of Instructional Cases
L.W. Bassett, R. Jahanshahi, R.H. Gold & Y.A. Fu,
London: Martin Dunitz, 1991, 320 pp. £65.00.
The plain blue cover hides what I found to be a very
interesting book.
The authors are two Radiologists and two Pathologists
from Los Angeles, and consequently some of the advice given
in the book probably reflects the cautious practice in the
United States. For example, it was implied that most clusters
of stippled calcification should undergo histopathological
study - some of the examples shown were at the benign end
of the spectrum in my opinion. Of course biopsy will be
required in some cases, but I suspect that many British
practitioners would often adopt a 'wait and see' policy.
A brief introduction of only ten pages covers the basic
aspects of mammography, including a distillation of the
major studies of mammographic screening for breast cancer.
Several other important topics are covered by short pithy
sections.
The importance of the false negative mammogram is
emphasised and rightly so. The authors clearly state that
'mammography cannot be considered a substitute for biopsy
in the presence of suspicious clinical findings.' Please note -
clinicians and radiologists.
Most of the book is devoted to 54 cases in which the
readers are able to test their skills in interpreting a wide
range of pathologically proven cases. Typical examples of
malignant and benign disease are shown. There are also good
examples of benign disease masquerading as malignancy and
vice versa. Each example is preceded by a few words of
history followed by the mammograms which are reproduced
in full size. Each case is followed by a description of the
mammographic findings and discussion of the mammog-
raphic and pathological features. I found the discussions
extremely useful, containing many gems of useful inform-
ation.
Histological materials has been included quite extensively
as the book is aimed at oncologists, radiotherapists and
surgeons with an interest in breast disease, as well as
radiologists.
Most of the reproductions adequately demonstrate the
stated abnormality. There has been a problem in reproducing
some of the more subtle areas ofmicrocalcification which are
not clearly seen in a few of the examples. In one or two cases
the microcalcifications have been rendered completely invisi-
ble!
Despite my reservations about some of the illustrations, I
thoroughly enjoyed reading this book and learned a lot from
it. I believe all involved in the management of breast disease
would find something of interest here. Trainees in diagnostic
radiology in particular would enjoy reading this book and
therefore inclusion in the radiology department's library is
recommended.
A.J. Booth